|
M&A
Dealmaking: How to Stay Ahead of the Curve
The record-breaking level of dealmaking activity in the pharmaceutical sector reveals profound strategic shifts occurring in the industry that will change the transactions field for companies out across the next five to ten years. Amid this surge in M&A activity, Michael Swanick asks: What are the crucial considerations pharma executives should weigh before sitting down at the deals table? ...Read more
Pricing
Sovaldi Spurs Managed Care Experts to Talk Specialty Drug Pricing
Sovaldi’s pricing has triggered a major and unexpected dialogue for the managed care experts. At last week’s Academy of Managed Care Pharmacy (AMCP) meeting in Boston, patient access advocates, pharma and payer representatives came together for a symposium entitled “Specialty Pharmacy and Patient Care: Are We at a Tipping Point?” Casey McDonald reports ...Read more
Global Health
TAG Touts Progress in Global Access to TB Drugs
TB advocacy campaigner Treatment Action Group (TAG) has reached a milestone in improving access to TB treatments. Sanofi’s reduction of the 340B federal discount program price of Priftin (rifapentine) from $73 to $51 and further in January to $32 per box is a historical win for the TB community, according Erica Lessem, TB/HIV Project Assistant Director
...Read more
Covance MarketPlace. Connect Right from the Start.
Find the right partner with the desire and resources to help you realize your molecule’s potential. Through our private, secure and exclusive online portal, you can share information about your molecule to potential investors or partners. It's one more innovative way to transform the profile and success of your program, delivered by the only global drug development partner with expertise spanning preclinical, clinical and commercial phases.
 Learn more
Sales & Marketing
Customer Engagement Isn’t Just About Physicians: It’s About Reps Too
The pharma industry has been preaching for years how reps need to develop a mutual beneficial relationship with doctors in which the healthcare providers can access the information they want, how and when they want it. There needs to be a focus on how to enable companies to bring that same level of engagement to their sales force, writes Karl Tiedemann
...Read more
Sales & Marketing
The Future of Digital in the Pharma Marketing Mix
Yes, digital is the future of marketing. But, says Mark Perlotto, brands and the people that use them don’t live in the future— they live now. And the question for marketers is the same today as it will be in 2114: Who is our audience, and what is the best way to communicate with them?
...Read more
|
Slow growth in developed economies or a slowdown in high growth markets: which concerns you the most?
